Related Experiment Videos
XH-14 analogues as adenosine antagonists
P J Scammells1, S P Baker, A R Beauglehole
1School of Biological and Chemical Sciences, Deakin University, Geelong, VIC, Australia. scam@deakin.edu.au
Bioorganic & Medicinal Chemistry
|November 5, 1998
Summary
Researchers synthesized new analogues of the potent adenosine antagonist XH-14. Structure-activity studies revealed that the 3-formyl and 5-(3-hydroxypropyl) groups are crucial for high A1 adenosine receptor affinity.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Organic Synthesis
Background:
- Adenosine receptors play critical roles in various physiological processes.
- Development of selective adenosine receptor antagonists is a key area in drug discovery.
- XH-14 is a potent antagonist of the A1 adenosine receptor.
Purpose of the Study:
- To synthesize novel analogues of XH-14 with modifications at the 2-, 5-, and 7-positions.
- To evaluate the structure-activity relationship (SAR) of these analogues for A1 adenosine receptor affinity.
- To identify key structural features responsible for high receptor binding.
Main Methods:
- Synthesis of benzofuran-3-carbaldehyde analogues.
- Radioligand binding assay using [3H]CPX to determine receptor affinity.
- Competitive binding studies to assess antagonist potency.
Main Results:
- Several novel analogues of XH-14 were successfully synthesized.
- The study identified the 3-formyl and 5-(3-hydroxypropyl) moieties as essential for high affinity to the A1 adenosine receptor.
- Modifications at the 2-position significantly impacted receptor binding.
Conclusions:
- The synthesized analogues provide valuable insights into the SAR of A1 adenosine receptor antagonists.
- The 3-formyl and 5-(3-hydroxypropyl) groups are critical pharmacophores for XH-14 activity.
- Further optimization based on these findings could lead to more potent and selective A1 adenosine receptor modulators.